Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2019 3
2021 4
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Nanoparticles for local delivery of siRNA in lung therapy.
Kubczak M, Michlewska S, Bryszewska M, Aigner A, Ionov M. Kubczak M, et al. Adv Drug Deliv Rev. 2021 Dec;179:114038. doi: 10.1016/j.addr.2021.114038. Epub 2021 Nov 3. Adv Drug Deliv Rev. 2021. PMID: 34742826 Review.
In Vitro Anticancer Properties of Copper Metallodendrimers.
Hołota M, Magiera J, Michlewska S, Kubczak M, Del Olmo NS, García-Gallego S, Ortega P, de la Mata FJ, Ionov M, Bryszewska M. Hołota M, et al. Among authors: kubczak m. Biomolecules. 2019 Apr 18;9(4):155. doi: 10.3390/biom9040155. Biomolecules. 2019. PMID: 31003561 Free PMC article.
Lipid-coated ruthenium dendrimer conjugated with doxorubicin in anti-cancer drug delivery: Introducing protocols.
Michlewska S, Garaiova Z, Šubjakova V, Hołota M, Kubczak M, Grodzicka M, Okła E, Naziris N, Balcerzak Ł, Ortega P, de la Mata FJ, Hianik T, Waczulikova I, Bryszewska M, Ionov M. Michlewska S, et al. Among authors: kubczak m. Colloids Surf B Biointerfaces. 2023 Jul;227:113371. doi: 10.1016/j.colsurfb.2023.113371. Epub 2023 May 24. Colloids Surf B Biointerfaces. 2023. PMID: 37244201 Free article.
Carbosilane ruthenium metallodendrimer as alternative anti-cancer drug carrier in triple negative breast cancer mouse model: A preliminary study.
Michlewska S, Maly M, Wójkowska D, Karolczak K, Skiba E, Hołota M, Kubczak M, Ortega P, Watala C, Javier de la Mata F, Bryszewska M, Ionov M. Michlewska S, et al. Among authors: kubczak m. Int J Pharm. 2023 Apr 5;636:122784. doi: 10.1016/j.ijpharm.2023.122784. Epub 2023 Feb 28. Int J Pharm. 2023. PMID: 36858135
14 results